These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Importance of molecular computer modeling in anticancer drug development. Geromichalos GD J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268 [TBL] [Abstract][Full Text] [Related]
36. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification. Iyanagi T Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904 [TBL] [Abstract][Full Text] [Related]
37. Identification of membrane-contacting loops of the catalytic domain of cytochrome P450 2C2 by tryptophan fluorescence scanning. Ozalp C; Szczesna-Skorupa E; Kemper B Biochemistry; 2006 Apr; 45(14):4629-37. PubMed ID: 16584198 [TBL] [Abstract][Full Text] [Related]
38. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel. Haines DC; Chen B; Tomchick DR; Bondlela M; Hegde A; Machius M; Peterson JA Biochemistry; 2008 Mar; 47(12):3662-70. PubMed ID: 18298086 [TBL] [Abstract][Full Text] [Related]
39. Protein dynamics and imidazole binding in cytochrome P450 enzymes. Verras A; Ortiz de Montellano PR Biochem Soc Trans; 2006 Dec; 34(Pt 6):1170-2. PubMed ID: 17073778 [TBL] [Abstract][Full Text] [Related]
40. The structure of microsomal cytochrome P450 2C5: a steroid and drug metabolizing enzyme. Johnson EF; Wester MR; Stout CD Endocr Res; 2002 Nov; 28(4):435-41. PubMed ID: 12530646 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]